文献速递骨质疏松与钙磷/甲状旁腺

长期传统治疗的原发性甲状旁腺功能减退症患者的肾钙质沉着症、肾功能障碍与结石

Nephrocalcinosis, Renal Dysfunction, and Calculi in Patients With Primary Hypoparathyroidism on Long-Term Conventional Therapy.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

在三级医疗中心对165例接受传统治疗的原发性甲状旁腺功能减退症(PH)患者进行观察性研究,发现肾钙质沉着症患病率为6.7%,14%的患者GFR低于60 mL/min/1.73 m2,肾结石患病率与165名健康对照相当(5% vs 3.6%,P = .58),10年传统治疗期间9%的患者出现肾钙质沉着症。

要点

  • PH患者肾钙质沉着症患病率6.7%,对照中未见。
  • 14%的PH患者GFR低于60 mL/min/1.73 m2,随访期FEPh升高是低GFR的显著预测因素。
  • PH患者肾结石患病率与对照相当(5% vs 3.6%,P = .58),10年传统治疗期间9%出现肾钙质沉着症。

核心结论

  • 6.7%的PH患者存在肾钙质沉着症,14%存在肾功能障碍,肾结石患病率与对照相似,10年传统治疗期间9%的患者出现肾钙质沉着症。

研究设计与样本

  • 三级医疗中心开展的一项观察性研究,共纳入165例接受传统治疗的PH患者,并以165名表面健康个体作为对照。

主要发现

  • 肾钙质沉着症在PH患者中占6.7%,对照组中未见。
  • 初诊时年龄小于15岁和血清钙磷乘积较高的患者风险更高。
  • 肾钙质沉着症与白内障及颅内钙化无显著关联。
  • PH患者与对照的肾结石患病率相当(5% vs 3.6%,P = .58)。
  • 14%的患者GFR低于60 mL/min/1.73 m2,随访期间FEPh升高是低GFR的显著预测因素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: There are concerns about the long-term safety of conventional therapy on renal health in patients with hypoparathyroidism. Careful audit of these would help comparisons with upcoming parathyroid hormone therapy. OBJECTIVE: We investigated nephrocalcinosis, renal dysfunction, and calculi, their predictors and progression over long-term follow-up in patients with primary hypoparathyroidism (PH). DESIGN AND SETTING: An observational study at a tertiary care center was conducted. PARTICIPANTS AND METHODS: A total of 165 PH patients receiving conventional therapy were evaluated by radiographs, ultrasonography, and computed tomography. Their glomerular filtration rate (GFR) was measured by Tc-99m-diethylenetriamine penta-acetic acid clearance. Clinical characteristics, serum total calcium, phosphorus, creatinine, hypercalciuria, and fractional excretion of phosphorus (FEPh) at presentation and during follow-up were analyzed as possible predictors of renal complications. Controls were 165 apparently healthy individuals. RESULTS: Nephrocalcinosis was present in 6.7% of PH patients but not in controls. Patients younger than 15 years at presentation and with higher serum calcium-phosphorus product were at higher risk. Nephrocalcinosis showed no significant association with cataract and intracranial calcification. Prevalence of renal calculi was comparable between hypoparathyroid patients and controls (5% vs 3.6%, P = .58). Fourteen percent of patients had a GFR less than 60 mL/min/1.73 m2. Increased FEPh during follow-up was the significant predictor of low GFR. Nephrocalcinosis developed in 9% of patients over 10 years of conventional therapy. CONCLUSION: A total of 6.7% of PH patients had nephrocalcinosis, and 14% showed renal dysfunction. Prevalence of renal calculi was similar in patients and controls. Nine percent of patients developed nephrocalcinosis over 10 years of conventional therapy.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Saha S, Kandasamy D, Sharma R, et al. Nephrocalcinosis, Renal Dysfunction, and Calculi in Patients With Primary Hypoparathyroidism on Long-Term Conventional Therapy. J Clin Endocrinol Metab. 2020. PMID: 31901096. doi:10.1210/clinem/dgz319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。